3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
10
Gemcitabine
8
Cyclophosphamide
7
Filgrastim
5
Docetaxel
5
Carboplatin
5
Trastuzumab
4
Surveys and Questionnaires
4
Nivolumab
4
Doxorubicin
4
Cisplatin
4
poly ICLC
3
pazopanib
3
atezolizumab
3
aldesleukin
3
Taxes
3
Radiotherapy
3
Paclitaxel
3
Oncolytic Virotherapy
3
Irinotecan
3
Ipilimumab
3
Injections
3
Drug Therapy
3
Cetuximab
3
Capecitabine
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
spartalizumab
2
palbociclib
2
liposomal doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Radionuclide Imaging
×
Breast
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled